Pneumonia News and Research

Latest Pneumonia News and Research

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

LMU scientists have investigated how most people's immune defenses are able to curb the coronavirus so effectively that pneumonia does not occur.

10 Mar 2022

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

A new study has evaluated the association of BZD use with the clinical outcomes of SARS-CoV-2 positive patients.

10 Mar 2022

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

The new drug nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled phase 3 clinical trial published in the New England Journal of Medicine.

9 Mar 2022

Elevated P2X7 receptor levels in COVID-19 patients correlate with disease severity

In a recent study posted to the bioRxiv preprint server, researchers demonstrated that the soluble P2X7 receptor is increased in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients. They also showed that the elevated P2X7 receptors correlated with coronavirus disease 2019 (COVID-19) severity.

9 Mar 2022

COVID-19 may cause brain shrinkage in some people

In a recent study posted to the journal Nature as an unedited manuscript, researchers assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated brain changes among United Kingdom (UK) Biobank patients.

8 Mar 2022

Study suggests recent common cold may actually lead to worse COVID-19 disease

A new study published in the Journal of Infectious Diseases shines an unexpected light on the notion that pre-existing immunity to common cold coronaviruses can protect us from coronavirus disease 2019 (COVID-19) – and reveals that this may actually put certain individuals at risk of more severe clinical presentations.

8 Mar 2022

Study reveals new insights on how immune system cells respond to disease-causing pathogens

In laboratory experiments involving a class of mutations in people with a rare collection of immune system disorders, Johns Hopkins Medicine researchers say they have uncovered new details about how immune system cells respond to disease-causing bacteria, fungi and viruses such as SARS-CoV-2.

8 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

Bacterial coinfection pervasiveness and antibiotic use in COVID-19 patients

In a recent study posted to the medRxiv* pre-print server, researchers conducted a meta-analysis to determine the bacterial coinfection and antibiotic usage prevalence in coronavirus disease 2019 (COVID-19) patients.

7 Mar 2022

Clinical outcomes of regdanvimab usage in patients with mild to moderate COVID-19

Researchers evaluated the effectiveness of regdanvimab on clinical outcomes in patients with mild to moderate COVID-19.

7 Mar 2022

Impact of humoral responses in COVID-19

New research discussed the function and impact of humoral immune responses in COVID-19.

7 Mar 2022

Severity of COVID-19 cases in the months of Alpha variant predominance compared to the Delta variant

The findings of the study demonstrated the higher occurrence of more severe cases during the predominance of the Alpha variant as compared to the Delta wave after adjusting the regression model for effects like age and status of vaccination.

7 Mar 2022

Study explores differentially expressed immune genes for COVID-19 patient stratification

In a new study, researchers determined the transcriptional signatures associated with the severity of COVID-19.

7 Mar 2022

The relative dynamics of infection with the Delta and Omicron SARS-CoV-2 variants in aged and young Syrian hamsters

Researchers demonstrated the relative pathogenicity of SARS-CoV-2 Omicron and Delta variants of concern in Syrian hamsters.

7 Mar 2022

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Researchers evaluated the association between cognitive impairment and clinical-functional variables in the coronavirus disease 2019 post-acute period.

7 Mar 2022

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled Phase 3 clinical trial.

3 Mar 2022

Pneumonia News and Research

Latest Pneumonia News and Research

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

Elevated P2X7 receptor levels in COVID-19 patients correlate with disease severity

COVID-19 may cause brain shrinkage in some people

Study suggests recent common cold may actually lead to worse COVID-19 disease

Study reveals new insights on how immune system cells respond to disease-causing pathogens

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Bacterial coinfection pervasiveness and antibiotic use in COVID-19 patients

Clinical outcomes of regdanvimab usage in patients with mild to moderate COVID-19

Impact of humoral responses in COVID-19

Severity of COVID-19 cases in the months of Alpha variant predominance compared to the Delta variant

Study explores differentially expressed immune genes for COVID-19 patient stratification

The relative dynamics of infection with the Delta and Omicron SARS-CoV-2 variants in aged and young Syrian hamsters

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in